Product Information
RISEDRONATE SODIUM 150 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $12.8176 per EA under NDC 59762040601. Its NADAC has been published 403 times since Dec 5, 2018.
FDA first approved this application on Mar 27, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
129; 21 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RISEDRONATE SODIUM HEMIPENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020835FDA Approved
3/27/1998
TE Code
AB
On Market Since
4/22/2008
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 150 MG TAB has been published 403 times since Dec 5, 2018, and over the history we have for it it has declined 70.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.8176 per EA |
|---|---|
| All-time high | $43.8038 (Jul 10, 2019) |
| All-time low | $9.8142 (May 22, 2024) |
| 52-week high | $17.6823 |
| 52-week low | $12.8176 |
| Median price | $17.6823 |
| Average price | $23.7705 |
| Largest weekly change | +58.0% (Aug 21, 2024) |
| Weeks tracked | 403 |
| Tracking since | Dec 5, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 150 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $12.8176 per EA (NDC 59762040601), effective Aug 19, 2026.
How has the price of RISEDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 150 MG TAB has declined 70.2%. It has been tracked across 403 weekly CMS publications since Dec 5, 2018.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 150 MG TAB?
Since Dec 5, 2018, the NADAC for RISEDRONATE SODIUM 150 MG TAB has ranged from a low of $9.8142 (May 22, 2024) to a high of $43.8038 (Jul 10, 2019), with a median of $17.6823 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 150 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RISEDRONATE SODIUM 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 150 MG TAB?
RISEDRONATE SODIUM 150 MG TAB (NDC 59762040601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.